Overview: When Yaz birth control pills were first introduced, they were heavily marketed as being a better type of oral contraceptive for the modern woman. In fact, Bayer’s advertising worked so well that it was the best-selling birth control pill in the United States in 2008 and 2009. As many women have come to realize however, Yaz is not all that it was hyped up to be; research has shown that the pill may increase the risk of blood clot and blood-clot related events, such as stroke, heart attack and pulmonary embolism. According to one woman’s lawsuit, the drug led to several of these severe, life-threatening complications and has shortened her life span.
- A Florida woman has filed a lawsuit alleging Yaz caused a stroke, pulmonary embolism, cardiac arrhythmia; she also needed to have her gallbladder removed
- The FDA has warned that use of birth control pills containing drospirenone such as Yaz can significantly increase the risk of blood clots
- An FDA-funded study found a 77 % increased risk of VTE and double the risk of ATE in woman who take such birth control pills
Product: Yaz®, Yasmin® (Drospirenone and Ethinyl Estradiol)
Manufacturer: Bayer AG
Side Effects & Complications
- Blood Clots
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Gallbladder Damage
- Heart Attacks
Lawsuit Alleges Pulmonary Embolism, Stroke, Heart Problems
The Plaintiff took Yaz from 2007 through 2010 due to the advice of her OBGYN. As an alleged result of using the medication, she has sustained permanent injuries and disability that require long-term care. The lawsuit alleges that Yaz caused the Plaintiff to suffer a stroke, pulmonary embolism and cardiac arrhythmia and gallbladder removal. She is alleging that the manufacturer, Bayer Healthcare Pharmaceuticals, was negligent and failed to adequately warn users about side effects.
There are currently thousands of Yaz and Yasmin lawsuits in the United States. Many of them have been filed into the multidistrict litigation pending in the U.S. District Court for the Southern District of Illinois (MDL No. 2100).
Yaz Associated with Blood Clots
Yaz and its predecessor Yasmin are birth control pills that contain the synthetic hormone drospirenone. Research has found that this class of oral contraceptives has a particularly high risk of blood clots, typically manifesting as deep vein thrombosis where a clot forms in the deep veins of the leg. The danger is that a part of this clot can come loose and make its way into the lungs, leading to a pulmonary embolism, or the heart or brain, leading to a heart attack or stroke, respectively. In April 2012, the U.S. Food and Drug Administration (FDA) updated the warning label on Yaz, Yasmin and other similar drugs to warn about these risks. A study funded by the agency has also found that drospirenone-containing birth control pills are associated with a 77 percent increased risk of blood clots in the veins and double the risk of clots in the arteries.